Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular Carcinoma [0.03%]
台湾中晚期肝细胞癌治疗共识声明
I-Cheng Lee,Hung-Wei Wang,Wei Teng et al.
I-Cheng Lee et al.
Intermediate-stage hepatocellular carcinoma (HCC) encompasses a diverse patient population that requires individualized treatment strategies and a multidisciplinary approach. Recent advancements in systemic therapy have expanded the therape...
Early oxidative protein modifications and gut damage/leakiness contribute to drug-induced acute liver failure [0.03%]
早期氧化性蛋白质修饰和肠道损害/渗漏参与药物致急性肝功能衰竭的作用
Wiramon Rungratanawanich,Ying Qu,Andrew Holmes et al.
Wiramon Rungratanawanich et al.
Correspondence to editorials (CMH-2025-0699) on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial" [0.03%]
关于“HK-660S治疗原发性硬化性胆管炎患者的安全性和有效性:一项随机双盲IIa期临床试验”的来信
Woo Hyun Paik,Heon Se Jeong,Do Hyun Park
Woo Hyun Paik
Correspondence to editorial on "Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in MASLD" [0.03%]
关于“氨基酸在MASLD肝糖异生和脂质生成中的作用”的社论的回信
Eiji Kakazu,Masaaki Mino,Tatsuya Kanto
Eiji Kakazu
Decoding Platelet Function in Liver Cirrhosis: A shift from Quantity to Quality [0.03%]
肝硬化中血小板功能的解析:从数量向质量转变
Vibhuti Jakhmola,Sukriti Baweja,Chhagan Bihari
Vibhuti Jakhmola
Contemporary Trends in Extrahepatic Mortality of Chronic Liver Disease in the United States from 2014 to 2023 [0.03%]
2014至2023年美国慢性肝病患者非肝脏死亡的流行趋势分析
Donghee Kim,Pojsakorn Danpanichkul,Karn Wijarnpreecha et al.
Donghee Kim et al.
Chih-Lin Lin,Jia-Horng Kao
Chih-Lin Lin
Through the implementation of hepatitis B vaccination and effective antiviral treatment over the past four decades, the HBsAg seroprevalence of the vaccinated generation dramatically decline. The incidence of HBV-related HCC also decreases....
HCC Surveillance After Curative Treatment: A New Frontier for Abbreviated MRI Editorial on: "Non-contrast MRI for Detection of Late Recurrent Hepatocellular Carcinoma After Curative Treatment: Comparison to CT" [0.03%]
治愈性治疗后的肝癌监测:简化的MRI的新前沿——短评:"治愈性治疗后晚期复发的肝细胞癌的检测:与CT相比的非对比MRI"
Hyungjin Rhee,Jin-Young Choi
Hyungjin Rhee